Education
About Us
Working with TipRanks
Follow Us
Cigna Corp (CI)
NYSE:CI
CI Stock Chart & Stats
$264.66
-$1.43(-0.51%)
At close: 4:00 PM EST
$264.66
-$1.43(-0.51%)
Day’s Range― - ―
52-Week Range$239.51 - $350.00
Previous CloseN/A
Volume191.22K
Average Volume (3M)1.92M
Market Cap
$70.70B
Enterprise Value$111.36B
Total Cash (Recent Filing)$6.03B
Total Debt (Recent Filing)$34.04B
Price to Earnings (P/E)11.7
Beta0.32
Next Earnings
Jan 29, 2026EPS Estimate
7.9Last Dividend Ex-Date
Sep 04, 2025Dividend Yield1.93%
Share Statistics
EPS (TTM)7.83
Shares Outstanding267,125,820
10 Day Avg. Volume2,931,965
30 Day Avg. Volume1,923,100
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.89
Price to Sales (P/S)0.31
P/FCF Ratio8.64
Enterprise Value/Market Cap1.58
Enterprise Value/Revenue0.42
Enterprise Value/Gross Profit4.14
Enterprise Value/Ebitda9.59
Forecast
1Y Price Target
$342.24Price Target Upside29.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement's reaffirmation of the 2025 adjusted EPS outlook suggests confidence in the company's near-term financial performance.
Investment StrategyCigna announced a $3.5B preferred stock investment in Shields Health Solutions, a leading provider of specialty pharmacy management solutions.
Regulatory StrategyThe introduction of a new rebate-free model is a big step in reducing the regulatory pressure that CI and other PBMs face.
Bears Say
Earnings ExpectationsThe company's proactive approach to recontacting pharmacy benefit manager contracts creates uncertainty and modest EPS growth expectations for 2026.
Market ReactionThe stock is down approximately 20% due to the market's reaction to the earnings reset, reflecting significant investor concern.
Transition CostsCigna needs to make upfront investments to transition to a new rebate-free PBM model, which involves dual expenses.
Cigna News
CI FAQ
What was Cigna Corp’s price range in the past 12 months?
Cigna Corp lowest stock price was $239.51 and its highest was $350.00 in the past 12 months.
What is Cigna Corp’s market cap?
Cigna Corp’s market cap is $70.70B.
When is Cigna Corp’s upcoming earnings report date?
Cigna Corp’s upcoming earnings report date is Jan 29, 2026 which is in 84 days.
How were Cigna Corp’s earnings last quarter?
Cigna Corp released its earnings results on Oct 30, 2025. The company reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19.
Is Cigna Corp overvalued?
According to Wall Street analysts Cigna Corp’s price is currently Undervalued.
Does Cigna Corp pay dividends?
Cigna Corp pays a Quarterly dividend of $1.51 which represents an annual dividend yield of 1.93%. See more information on Cigna Corp dividends here
What is Cigna Corp’s EPS estimate?
Cigna Corp’s EPS estimate is 7.9.
How many shares outstanding does Cigna Corp have?
Cigna Corp has 267,125,820 shares outstanding.
What happened to Cigna Corp’s price movement after its last earnings report?
Cigna Corp reported an EPS of $7.83 in its last earnings report, beating expectations of $7.64. Following the earnings report the stock price went down -17.391%.
Which hedge fund is a major shareholder of Cigna Corp?
Currently, no hedge funds are holding shares in CI
Cigna Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$342.24 (29.31% Upside)
$342.24 (29.31% Upside)
Blogger Sentiment
Bullish
CI Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 678.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $999.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.5%
Last 30 Days ▲ 12.0%
Last 30 Days ▲ 12.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.64%
12-Months-Change
Fundamentals
Return on Equity
14.65%
Trailing 12-Months
Asset Growth
0.41%
Trailing 12-Months
Company Description
Cigna Corp
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
CI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Cigna Group demonstrated strong revenue and earnings performance, driven by strategic investments and client retention. However, the company faces challenges with margin pressure in its Pharmacy Benefit Services segment and increased medical care ratios, particularly in the individual exchange business. While there are growth opportunities in specialty services and strategic client renewals, the transition to a new rebate-free model presents short-term challenges.View all CI earnings summariesCI Stock 12 Month Forecast
Average Price Target
$342.24
▲(29.31% Upside)
Technical Analysis
Ownership Overview
0.34% Insiders
28.64% Mutual Funds
0.65% Other Institutional Investors
48.67% Public Companies and Individual Investors